• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经活检证实的巨细胞动脉炎和孤立性风湿性多肌痛患者的干扰素-γ基因微卫星多态性

Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.

作者信息

Gonzalez-Gay M A, Hajeer A H, Dababneh A, Garcia-Porrua C, Amoli M M, Llorca J, Ollier W E R

机构信息

Division of Rheumatology, Hospital Xeral-Calde, Lugo, Spain.

出版信息

Clin Exp Rheumatol. 2004;22(6 Suppl 36):S18-20.

PMID:15675129
Abstract

OBJECTIVES

Inflammatory cytokines are implicated in the pathogenesis of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR). In this study we have examined the potential association of a CA repeat polymorphism in the first intron of the interferon gamma (IFN-gamma) gene with disease susceptibility and clinical expression of these conditions.

METHODS

Seventy-nine patients with isolated PMR, 59 biopsy-proven GCA patients and 129 ethnically matched controls from Lugo (NW Spain) were studied. Patients and controls were genotyped by molecular methods for the microsatellite dinucleotide (CA) repeat within the first intron of IFN-gamma gene.

RESULTS

No significant differences in the distribution of alleles for the IFN-gamma gene polymorphism between GCA and isolated PMR patients and controls were found. However, the frequency of IFN-gamma allele *4 (128 bp) was reduced in GCA patients (33.1%) compared with isolated PMR patients (46.2%). Also, GCA patients with visual ischemic manifestations exhibited a significantly reduced frequency of IFN-gamma allele *4 compared with those without visual manifestations (17.9% versus 42.5%; p = 0.05 [OR: 0.36, 95% CI: 0.13-1.00]). Moreover, allele *3 (126 bp) was over-represented in the GCA patients with visual ischemic manifestations (71.4% versus 44.4% in the remaining GCA patients; p = 0.01 [OR = 3.13, 95% CI: 1.27-7.68]).

CONCLUSIONS

In GCA, IFN-gamma functional polymorphisms are associated with clinical manifestations of severity rather than susceptibility to this vasculitis.

摘要

目的

炎性细胞因子与巨细胞动脉炎(GCA)和风湿性多肌痛(PMR)的发病机制有关。在本研究中,我们检测了干扰素γ(IFN-γ)基因第一内含子中CA重复多态性与这些疾病易感性及临床表型之间的潜在关联。

方法

对来自西班牙西北部卢戈的79例孤立性PMR患者、59例经活检证实的GCA患者以及129名种族匹配的对照者进行研究。采用分子方法对患者和对照者的IFN-γ基因第一内含子中的微卫星二核苷酸(CA)重复进行基因分型。

结果

未发现GCA患者、孤立性PMR患者及对照者之间IFN-γ基因多态性等位基因分布有显著差异。然而,与孤立性PMR患者(46.2%)相比,GCA患者中IFN-γ等位基因4(128 bp)的频率降低(33.1%)。此外,有视觉缺血表现的GCA患者中IFN-γ等位基因4的频率显著低于无视觉表现的患者(17.9%对42.5%;p = 0.05 [OR:0.36,95% CI:0.13 - 1.00])。而且,等位基因*3(126 bp)在有视觉缺血表现的GCA患者中占比过高(71.4%对其余GCA患者中的44.4%;p = 0.01 [OR = 3.13,95% CI:1.27 - 7.68])。

结论

在GCA中,IFN-γ功能多态性与该血管炎的严重程度临床表现相关,而非易感性相关。

相似文献

1
Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.经活检证实的巨细胞动脉炎和孤立性风湿性多肌痛患者的干扰素-γ基因微卫星多态性
Clin Exp Rheumatol. 2004;22(6 Suppl 36):S18-20.
2
IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.位于 -174 位点的白细胞介素 -6 启动子多态性可调节经活检证实的巨细胞动脉炎中风湿性多肌痛的表型表达。
Clin Exp Rheumatol. 2002 Mar-Apr;20(2):179-84.
3
Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中促肾上腺皮质激素释放激素启动子多态性
Clin Exp Rheumatol. 2002 Mar-Apr;20(2):133-8.
4
Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.巨细胞动脉炎和风湿性多肌痛与不同肿瘤坏死因子微卫星多态性的关联。
Arthritis Rheum. 2000 Aug;43(8):1749-55. doi: 10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K.
5
Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中疾病易感性和严重程度的遗传标记。
Semin Arthritis Rheum. 2003 Aug;33(1):38-48. doi: 10.1053/sarh.2002.50025.
6
Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.风湿性多肌痛/巨细胞动脉炎中细胞间黏附分子1基因多态性:与疾病风险及严重程度的关联
J Rheumatol. 2000 May;27(5):1215-21.
7
Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.西班牙西北部经活检证实的巨细胞动脉炎患者中,功能性-94ins/delATTG NFKB1启动子多态性与易感性及临床表型缺乏相关性。
J Rheumatol. 2006 Feb;33(2):285-8.
8
Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.活检证实为巨细胞动脉炎的风湿性多肌痛并不构成一个不同的亚组,而是与孤立性风湿性多肌痛有所不同。
J Rheumatol. 1998 Sep;25(9):1750-5.
9
C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.西班牙西北部经活检证实的巨细胞动脉炎中C反应蛋白基因多态性
J Rheumatol. 2009 Feb;36(2):341-6. doi: 10.3899/jrheum.080707.
10
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis.巨细胞动脉炎中 Toll 样受体 4(TLR4)基因多态性。
Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S40-4.

引用本文的文献

1
Traditional and Emerging Strategies for Managing Polymyalgia Rheumatica: Insights into New Treatments.治疗巨细胞动脉炎的传统与新兴策略:新疗法洞察
J Clin Med. 2024 Oct 29;13(21):6492. doi: 10.3390/jcm13216492.
2
Vascular-adhesion protein 1 in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中的血管黏附蛋白1
Front Med (Lausanne). 2024 Aug 14;11:1448157. doi: 10.3389/fmed.2024.1448157. eCollection 2024.
3
Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What-A Critical Review.
正电子发射断层扫描/计算机断层扫描在风湿性多肌痛中的应用:时机与目的——一项批判性综述
Diagnostics (Basel). 2024 Jul 17;14(14):1539. doi: 10.3390/diagnostics14141539.
4
Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling.巨细胞动脉炎的组织损伤的最新认识:从急性炎症反应到不适当的组织重塑。
Cells. 2024 Feb 29;13(5):430. doi: 10.3390/cells13050430.
5
Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis.风湿性多肌痛和巨细胞动脉炎中糖皮质激素抵抗的遗传易感性及治疗结果
J Clin Med. 2019 Apr 27;8(5):582. doi: 10.3390/jcm8050582.
6
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?综述:巨细胞动脉炎的疾病亚型目前有哪些证据?
Arthritis Rheumatol. 2018 Sep;70(9):1366-1376. doi: 10.1002/art.40520. Epub 2018 Jul 30.
7
Visual loss and other cranial ischaemic complications in giant cell arteritis.巨细胞动脉炎所致视力丧失和其他颅缺血性并发症。
Nat Rev Rheumatol. 2017 Aug;13(8):476-484. doi: 10.1038/nrrheum.2017.98. Epub 2017 Jul 6.
8
Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.经活检证实的巨细胞动脉炎患者的视觉并发症:一项基于人群的研究。
J Rheumatol. 2016 Aug;43(8):1559-65. doi: 10.3899/jrheum.151033. Epub 2016 Jun 1.
9
Cytokine gene considerations in giant cell arteritis: IL10 promoter polymorphisms and a review of the literature.巨细胞动脉炎中的细胞因子基因考虑:IL10 启动子多态性和文献综述。
Clin Rev Allergy Immunol. 2014 Aug;47(1):56-64. doi: 10.1007/s12016-013-8405-8.
10
Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.干扰素-γ基因变异和细胞间黏附分子-1 参与泛发性白癜风的发病和进展。
J Interferon Cytokine Res. 2013 Nov;33(11):646-59. doi: 10.1089/jir.2012.0171. Epub 2013 Jun 18.